The causes of MHC-I-opathies in cellular stress
The causes of MHC-I-opathies in cellular stress
批准号:
460154834
负责人:
Professor Dr. Sebastian Springer
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Major histocompatibility complex (MHC) class I molecules (termed human leukocyte antigen (HLA I in human) are essential for mounting a cytotoxic adaptive response to intracellular pathogens and tumors. The specificity of the adoptive response relies on the accurate and efficient presentation of peptide fragments from non-self (e.g., viral or neoplastic) proteins by one of each six potentially dif-ferent HLA I molecules from two equidominantly expressed alleles of HLA-A, HLA-B and HLA-C loci in each individual. Discrimination of self from non-self is safeguarded by the elimination of auto-reactive T cells. Nevertheless, a group of autoreactive diseases (e.g. ankylosing spondylitis and oth-er spondyloarthropathies, Behçet’s disease, psoriasis, birdshot chorioretinopathy) display a strong genetic link to individual HLA I alleles. Accumulation of vast genetic data over the last four decades has recently lead to classification of those autoreactive diseases as MHC-I-opathies. Interestingly, in diseased individuals, disease-related CD8+ T cell responses to specific peptide-HLA I complexes have not been detected. This suggests that there are additional immune mechanisms (e.g innate response from NK cells directed towards HLA-I; cellular stress), independent of the presented peptides. Our previous work on numerous HLA I molecules supports the idea that certain HLA I allo-types can be biochemically unstable, and that low protein stability can result in intracellular accumu-lation of misfolded HLA I proteins. In such cases, antigen presentation by HLA I is diminished at the cell surface, and accumulated HLA I can stimulate cellular stress pathways such as unfolded protein response (UPR). In this work, we will determine the stability of each individual HLA I protein associated with MHC-I-opathies, assess their link to cellular stress, and define common structural features among them. Finally, according to our expertise, we will perform screens with small molecules to improve their stability and prevent pathological phenotypes in cellular models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Small molecules to manipulate peptide binding to MHC class I molecules, an optimized method for the generation of MHC tetramers by peptide exchange
-
批准号:310813447
-
项目类别:Research Grants (Transfer Project)
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Professor Dr. Sebastian Springer
-
依托单位:
Molecular cell biology of MHC class I retention by the gp40 protein of the murine cytomegalovirus
-
批准号:287481932
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Professor Dr. Sebastian Springer
-
依托单位:
The intracellular quality control mechanism of major histocompatibility complex class I molecules studied by controlled peptide delivery to cells - a combined cell biological, biochemical, and biophysical investigation
-
批准号:200883174
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Professor Dr. Sebastian Springer
-
依托单位:
Endocytic sorting of MHC class I molecules
-
批准号:190867601
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Professor Dr. Sebastian Springer
-
依托单位:
Enhancement of peptide binding to MHC class I molecules by small compounds - a combined biochemical and computational investigation
-
批准号:161303304
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Professor Dr. Sebastian Springer
-
依托单位:
The Regulated Intracellular Trafficking and Function of the Chaperones of the MHC Class I Peptide Loading Complex
-
批准号:5419741
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2004
-
负责人:Professor Dr. Sebastian Springer
-
依托单位:
Decrypting MHC class I trafficking in cross-presentation
-
批准号:530005650
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Sebastian Springer
-
依托单位:
Cell surface clusters of MHC class I molecules: origin, structure, and functions
-
批准号:447012451
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Sebastian Springer
-
依托单位:
国内基金
海外基金
登录
查看更多内容
MHC-I/CD14介导CD8+T细胞免疫抑制促进去势抵抗前列腺癌免疫逃逸的研究
-
批准号:2026JJ50277
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:钟上伟
-
依托单位:
去泛素化酶USP9X调控抗原呈递分子MHC-I的机制研究
-
批准号:JCZRQNB202600282
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
西黄丸通过m6A修饰介导YTHDF2/FAM13A/STUB1轴调控PCSK9-MHC-I信号逆转乳腺癌免疫逃逸的机制研究
-
批准号:2026JJ30083
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谢小兵
-
依托单位:
BCAT2调控氨基酸代谢重编程抑制MHC-I类分子组蛋白乙酰化修饰协助免疫逃逸的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:蔡智勇
-
依托单位:
雷公藤衍生物LLDT-8通过调控NLRC5/MHC-I信号通路治疗多发性肌炎的机制研究
-
批准号:JCZRYB202500090
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
短程放疗通过IFN-β-CXCR3/MHC-II轴协同直肠癌化疗免疫治疗的分子机制研究
-
批准号:JCZRLH202500227
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
前纤维蛋白1促进MHC-I自噬性降解导致非小细胞肺癌免疫治疗耐药的机制研究
-
批准号:2025JJ50555
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:卢义晨
-
依托单位:
MHC-E限制性CD8+调节性T细胞抑制抗肿
瘤免疫反应的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:王蕾
-
依托单位:
基于ILF3-DNMT1-MHC-I途径诱导免疫逃逸探讨骨肉瘤免疫检查点抑制剂治疗原发耐药的分子机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:邹华
-
依托单位:
肿瘤相关成纤维细胞通过CNOT4/MHC-I通
路介导胰腺癌免疫逃逸的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:练国达
-
依托单位: